Medications

FDA approves Regeneron's eye injection Eylea

(AP) -- Regulators on Friday approved Regeneron Pharmaceuticals Inc.'s drug Eylea, an injection designed to treat a common cause of blindness in older people.

Oncology & Cancer

Small molecules shed light on cancer therapies

Patients suffering from an aggressive brain cancer will benefit from the results of a University of Illinois study that could advance the development of targeted gene therapies and improve prognosis.

Other

Fraunhofer MEVIS: New procedure to make brain surgery safer

To increase patient safety in clinical practice and minimize risks and damage that may arise during surgery, computer support and digital medical imaging are key technologies. Before brain operations, neurosurgeons can now ...

page 26 from 26